Rheumatoid Arthritis
FDA Approves Biogen’s Biosimilar, Challenging Roche’s Actemra Dominance in the Market
Anika Sharma
Biogen has achieved a remarkable milestone while contemplating the future of its biosimilars division. The company proudly announced that its ...
Sandoz Enters US Immunology Market with Launch of High-Concentration Formulation Hyrimoz
SG Tylor
Source – Novartis On July 1, 2023, Sandoz made an announcement regarding the availability of their biosimilar Hyrimoz (adalimumab-adaz) injection ...
